Primary Aldosteronism LC-MS/MS-specific Cutoffs

CompletedOBSERVATIONAL
Enrollment

396

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Primary Aldosteronism
Interventions
DIAGNOSTIC_TEST

Captopril Challenge Test

Patients received 50 mg captopril orally in the morning after sitting or standing for at least two hours. PAC and PRC were measured using mass spectrometry two hours after administration of capopril.

Trial Locations (2)

400016

Qifu Li, Chongqing

Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
collaborator

Chinese PLA General Hospital

OTHER

collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

lead

Chongqing Medical University

OTHER

NCT05959863 - Primary Aldosteronism LC-MS/MS-specific Cutoffs | Biotech Hunter | Biotech Hunter